Trends in bacterial resistance in a tertiary university hospital over one decade

Brazilian Journal of Infectious Diseases

Volumn 17, Issue 4, 2013, Pages 480-482

  Rubio, Fernando Góngora ^a   Oliveira, Viviane Decicera Colombo ^a   Rangel, Regina Mara Custódio ^b   Nogueira, Mara Corrêa Lelles ^a   Almeida, Margarete Teresa Gottardo ^a  

^a FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

^b HOSPITAL DE BASE   (Brazil)

Author keywords

Bacteria; Multiresistance; Trends

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; OXACILLIN; PENICILLIN DERIVATIVE; POLYMYXIN B; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CITROBACTER FREUNDII; COAGULASE NEGATIVE STAPHYLOCOCCUS; DISEASE ASSOCIATION; ENTEROCOCCUS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL ADMISSION; HOSPITAL INFECTION; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MULTIDRUG RESISTANCE; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; TEACHING HOSPITAL; TERTIARY HEALTH CARE; TREND STUDY; UNIVERSITY HOSPITAL; VANCOMYCIN RESISTANT ENTEROCOCCUS;

BACTERIA; MULTIRESISTANCE; TRENDS;

ANTI-BACTERIAL AGENTS; BRAZIL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITALS, UNIVERSITY; HUMANS; INTENSIVE CARE UNITS; TERTIARY HEALTHCARE;

EID: 84880963571     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2012.12.004     Document Type: Article

References (8)

1. Urgently needed: new antibiotics. Lancet 2009, 374:1868.
2. Lautenbach E. Antimicrobial resistance in gram-negative pathogens: crafting the tools necessary to navigate the long ascent out of the abyss. J Infect Dis 2009, 200:838-840.
3. Mera R.M., Miller L.A., Amrine-Madsen H., Sahm D.F. Acinetobacter baumannii 2002-2008: increase of carbapenem-associated multiclass resistance in the United States. Microb Drug Res 2010, 16:209-215.
4. Johnson J.K., Smith G., Lee M.S., et al. The role of patient-to-patient transmission in the acquisition of imipenem-resistant Pseudomonas aeruginosa colonization in the intensive care unit. J Infect Dis 2009, 200:900-905.
5. Shorr A.F. Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit. Crit Care Med 2009, 37:1463-1469.
6. Styers D., Sheehan D.J., Hogan P., Sahm D.F. Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann Clin Microbiol Antimicrobial 2006, 5:9.
7. Dalla Costa L.M., Souza D.C., Martins L.T., et al. Vancomycin-resistant Enterococcus faecium: first case in Brazil. Braz J Infect Dis 1998, 2:160-163.
8. Góngora-Rubio F., Pignatari A.C., Costa L.M., Bortolloto V.I., Machado A.M., De Góngora D.V. Clinical significance, epidemiology and microbiology of coagulase-negative staphylococcal nosocomial bacteremia at a teaching hospital. Rev Assoc Med Bras 1997, 43:9-14.